Vaxxilon

Switzerland
Saint-Ursanne, Jura, Switzerland

Company profile

Vaxxilon company profile

Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines. Headquartered near Basel, Switzerland with research labs in Berlin, the Vaxxilon team is advancing several vaccine candidates for the prevention of major infectious diseases.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2015-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Last funding
Grant / $1.4M / 2019-08-20
Investors
1
Lead investors
1
Founders
2
Exited on
2020-07-23

Founders and investors

Founders

Peter SeebergerTom Monroe

Lead investors

CARB-X

Investors

CARB-X